Recent news

Israeli viral vaccines co SynVaccine raises $1.7m

01 Oct, 2017

SynVaccine has recently been awarded the European Commission`s Horizon 2020 SME Instrument Phase 1 grant

28 June, 2017

Second prize award in the ITTN start-up competition

25 May, 2016

SynVaccine finalist at the Berlin Falling Walls Venture competition, one of 3 top science based start-ups of 2014

December 2014


SynVaccine has been declared one of 3 top science based start-up of the Year (2014) by the a jury of 18 leaders from industry, investment and academics at the Falling Walls Venture competition.  

More than 25 outstanding science based start-up companies from around the world presented their business ideas  at the global forum Falling Walls Venture in Berlin. Nominated by leading international academic institutions and venture capitalists, each start-up had only five minutes to convince a distinguished jury of their business concepts.  SynVaccine was chosen to be one of the three most promising start-ups of the year 2014.